Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Eating Well (or at Least Not terribly) at Fast Food Resturants
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Government & Policy Articles

President's Win Is Reprieve For 'Obamacare'
USDA Food Recalls Update
Government Recoups Record $4 Billion from Healthcare Defrauders
Some Doctors Dispute Benefits Of Early Diagnosis
Front Labels on Food Packages Are Misleading
The Healthcare Bill: We're Confused, But Our Opinions Are Very Firm Nevertheless
President Obama Signs Healthy, Hunger-Free Kids Act of 2010 Into Law
Traveling With a Pump: TSA Regulations
The Center for Medicare and Medicaid Innovation is Introduced
JDRF Applauds Congress for Passage of $300 Million for Type 1 Diabetes Research and Thanks Supporters for Advocacy Efforts for Special Diabetes Program Renewal
Government & Policy Archives
Browse the Government & Policy Archives
Subscribe to the Legal RSS Feed
Print | Email | Share | Comments (0)

Galvus Approval Delayed While FDA Reviews Safety Data

Feb 1, 2007

Novartis reports that there will be a three-month delay in approval for its experimental diabetes drug, Galvus, due to the FDA’s request for additional safety data.

On November 13, 2006, Novartis announced that it is submitting further data to the FDA, “meaning that the U.S. regulator’s decision on approving the product will probably come at the end of February, 2007, three months later than expected.”

Galvus is a DPP-IV inhibitor that works by enhancing the body’s own ability to lower blood sugar levels. Merck Co.’s Januvia is also a DPP-IV inhibitor, which was granted FDA approval in October 2006.

Categories: Blood Sugar, Diabetes, Diabetes, Government & Policy, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Feb 1, 2007

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.